Chronic inorganic nitrate supplementation does not improve metabolic health and worsens disease progression in mice with diet-induced obesity.

Alice P Sowton,Lorenz MW Holzner,Fynn N Krause,Ruby Baxter,Gabriele Mocciaro,Dominika K Krzyzanska,Magdalena Minnion,Katie A O'Brien,Matthew C Harrop,Paula M Darwin,Benjamin D Thackray,Michele Vacca,Martin Feelisch,Julian L Griffin,Andrew J Murray

DOI: https://doi.org/10.1101/2024.07.04.602070

2024-07-08

Abstract:Inorganic nitrate (NO ) has been proposed to be of therapeutic use as a dietary supplement in obesity and related conditions including the Metabolic Syndrome (MetS), type-II diabetes and metabolic dysfunction associated steatotic liver disease (MASLD). Administration of NO to endothelial nitric oxide synthase-deficient mice reversed aspects of MetS, however the impact of NO supplementation in diet-induced obesity is not well understood. Here we investigated the whole-body metabolic phenotype and cardiac and hepatic metabolism in mice fed a high-fat high-sucrose (HFHS) diet for up to 12-months of age, supplemented with 1 mM NaNO (or NaCl) in their drinking water. HFHS-feeding was associated with a progressive obesogenic and diabetogenic phenotype, which was not ameliorated by NO . Furthermore, HFHS-fed mice supplemented with NO showed elevated levels of cardiac fibrosis, and accelerated progression of MASLD including development of hepatocellular carcinoma in comparison with NaCl-supplemented mice. NO did not enhance mitochondrial β-oxidation capacity in any tissue assayed and did not suppress hepatic lipid accumulation, suggesting it does not prevent lipotoxicity. We conclude that NO is ineffective in preventing the metabolic consequences of an obesogenic diet and may instead be detrimental to metabolic health against the background of HFHS-feeding. This is the first report of an unfavorable effect of long-term nitrate supplementation in the context of the metabolic challenges of overfeeding, warranting urgent further investigation into the mechanism of this interaction.

Physiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is whether long - term supplementation of inorganic nitrate (NO_3^-) can improve metabolic health in diet - induced obese mice. Specifically, the researchers hope to verify the following hypotheses through this study:

- By enhancing the bioavailability of nitric oxide (NO), inorganic nitrate can improve symptoms such as metabolic syndrome (MetS), type 2 diabetes (T2DM) and metabolic - dysfunction - associated steatosis (MASLD) caused by a high - fat high - sucrose (HFHS) diet.
- Whether inorganic nitrate can delay the development of metabolic and mitochondrial disorders in high - fat high - sucrose diet mice by regulating tissue mitochondrial function.

However, the research results show that inorganic nitrate not only fails to improve these metabolic problems, but also exacerbates the progression of the disease in some aspects, such as increasing cardiac fibrosis and accelerating the process of MASLD, and even leading to the occurrence of hepatocellular carcinoma. This indicates that in the context of diet - induced obesity, long - term supplementation of inorganic nitrate may have an adverse effect on metabolic health, and further research is needed to explore its mechanism.